Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase 2/3 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Hypoxia 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Nitroglycerin × Clear all
NCT01171170 2020-09-28

NVALT12

Dutch Society of Physicians for Pulmonology and Tuberculosis

Phase 2 Completed
223 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01210378 2019-02-15

Nitroglycerin

Maastricht Radiation Oncology

Phase 2 Terminated
47 enrolled
Thoracic

Hypoxia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡